<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Female Reproductive Pathology</title>
    <meta name="Author" content="Andy Vo">

    <link rel="stylesheet" href="repro_styles.css">
    <style type="text/css">
        table#PCOS, table#PCOS tr {
            border: 0
        }
        table#PCOS tr:nth-child(1) td {
            border-top: 0;
        }
        table#PCOS tr:nth-child(1) td {
            border-top: 0;
        }
        table#PCOS tr:nth-child(2) td {
            border-bottom: 0;
        }
        table#PCOS td:nth-child(1) {
            border-top: 0;
            border-left: 0
        }
        table#PCOS td:nth-child(3) {
            border-bottom: 0;
            border-right: 0
        }
        table#PCOS2, table#PCOS2 tr, table#PCOS2 tr td {
            border: 0;
            padding: 0 1rem;
        }
    </style>

</head>
<body>
    <h1>Repro #5 - Female Reproductive Pathology</h1>
    <hr>
    <div class="ToC">
        <b>Table of Content</b>
        <ol type="1" class="ToC">
            <li><a href="#amenorrhea">Amenorrhea</a></li>
            <li><a href="#femaleinfertility">Female Infertility</a></li>
            <li><a href="#pcos">Polycystic Ovarian Syndrome</a></li>
        </ol>
    </div>

    <h2>Amenorrhea</h2>
    <hr>
    <p style="margin-top: 0;"><b>Primary amenorrhea</b> is definied as either (1) no period by age 14 in the absence of growth or development of 2º sexual characteristics, or (2) no period by the age of 16. <b>Secondary amenorrhea</b> is defined the absence of a period for a length of time equalivent at least 3 cycles or 6 months <i>in a previously menstruating woman</i>.</p>
    <p>Amenorrhea can be caused by disorders of:
    <ul>
        <li><u>Chromosomal abnormalities:</u> Turner syndrome (most common cause of 1º amenorrhea)</li>
        <li>Endocrine dysfunction</li>
        <ul>
            <li><u>Hypothalamus:</u> low BMI, rough and dry skin, fine hairs on back and buttocks, ↓ FSH, ↓ estradiol. ↓ GnRH pulsatility, intracranial mass interrupting pituitary stalk, acquired hypopituitarisum (Sheehan's syndrome), Kallmann's syndrome &rarr; <b>Hypogonadotropic hypogonadism</b> </li>
            <li><u>Anterior pituitary:</u> ↑ GnRH, ↓ FSH/LH</li>
            <li><u>Ovary:</u> ↑ everything but estrogen and progesterone</li>
            <li><u>Androgen insentivity:</u> 46, XY with external female genitalia, scant pubic and axillary hair, and rudimentary vagina; uterus and fallopian tubes absent due to anti-Müllerian hormone from testes. Nl functioning testes within labia majora, need to remove to prevent malignancy. Labs show ↑ testosterone, estrogen, LH.</li>
            <li><u>Hypothyroidism:</u> common and can cause amenorrhea, could be consequence of non-functional anterior pituitary</li>
            <li><u>Hyperprolactinemia:</u> common and can affect menstural cycle</li>
        </ul>
        <li>Genital outflow tract obstructution due to:</li>
            <ul>
                <li><u>Müllerian agenesis (Mayer-Rokintasky-Küster-Hauser syndrome):</u> lack of uterine development with fully developed 2&deg; sexual characteristics (functional ovaries)</li>
                <li><u>Imperforate hymen/Transverse vaginal septum:</u> nl FSH, LH, estradiol. Mostly likely nl uterus, tubes, and ovaries, though can overlap with other Müllerian anomalies. Only sign is on pelvic exam. <b>Eugonadotropic 1º amenorrhea</b></li>
                <li><u>Asherman's syndrome (intrauterine adhesions or intrauterine synechiae):</u> occurs when scar tissue forms inside the uterus and/or the cervix.</li>
            </ul>
    </ul>
    </p>

    <h2 id="femaleinfertility">Female Infertility</h2>
    <hr>
    <p style="margin-top: 0;">Clinicially, <b>infertility</b> is defined as faliure of a couple to conceive within a period fo time (12 mos if woman &lt;&nbsp;35 y/o, 6 mos inf woman &ge;&nbsp;35 y/o. While "infertility" is often used, <i>subfertility</i> is a more accurate diagnosis prior to establishing the cause of the infertility. Another term to be familiar with is <b>fecundability</b>, the probability of a woman to conceive within one month<sup>&#x1f534;&#x1f7e1;</sup>. The "normal" value of fecundability is 20% (according to various sources).</p>
    <p>The WHO classify causes of female infertility into 3 classes:
        <ul>
            <li>Hypogonadtropic hypogonadism (5&#8209;10%)</li>
            <li>Normogonadotropic normoestrogenic anovulation (70&#8209;85%)</li>
            <li>Hypergonadotropic hypoestrogenic anovulation (10&#8209;30%)</li>
        </ul>
    </p>
    <p>Treatments for infertility include: oral medication (ex. clomiphene citrate, letrozole), injectable medication (SQ recombinant FSH/LH/hCG), intrauterine insemination, and IVF.  When using clomiphene, it is important to slowly step up the dose from 37.5-75 IU/d until serum FSH reaches the threshold concentration. Once this concentration is reached, the dosage is then stepped down back then stopped completely. Clomiphene is administered approximately 4 days after menses starts.</p>
    <div style="margin: auto; vertical-align: middle;">
        <img src="img/clomiphene_protocol1.png" alt="clomiphene administered after 4 days of menses starting" width="40%"><img src="img/clomiphene_protocol2.png" alt="clomiphene step up and step down protocol" width="40%">
    </div>
    <p>The risks of these include multiple pregnancies, ovarian cysts, and cancer (?).</p>

    <h2>Polycystic Ovarian Syndrome (PCOS)</h2>
    <hr>
    <p style="margin-top: 0;">The diagnostic criteria of PCOS are:</p>
    <table id="PCOS" style="">
        <tr>
            <td>NIH criteria</td>
            <td>Rotterdam criteria</td>
            <td>PCOS Society guidelines</td>
        </tr>
        <tr>
            <td>Hyperandrogenism<br>Oligo-/anovulation</td>
            <td><u>Two of the following</u>:<br>Hyperandrogenism<br>Oligo-/anovulation<br>Polycystic ovarian (PCO) morphology<sup>*</sup></td>
            <td>Hyperandrogenism<br>Oligo-/anovulation <u>OR</u> PCO morphology</td>
        </tr>
    </table><span style="font-size: small;"><sup>*</sup>PCO is defined &ge;12 follicles in <i>each</i> ovary 2&#8209;9&nbsp;mm in diameter.</span>
        
    <p>Other signs observed in patients with PCSO includes obesity (&ge;50%), HTN, dyslipidemia, imparied glucose tolerance, DM2, and metabolic syndrome. PCOS is a diagnosis of (reasonable) exclusion.  Its differential include:
        <table id="PCOS2">
            <tr>
                <td style="text-align: left;">
                    <ul style="margin: 0;">
                        <li>Hypothyroidism</li>
                        <li>Ovarian failure</li>
                        <li>Hyperprolactinemia</li>
                        <li>Hypothalmic</li>
                        <li>Pregnancy</li>
                    </ul>
                </td>
                <td style="text-align: left;"">
                    <ul style="margin: 0;">
                        <li>Late onset congenital adrenal hyperplasia</li>
                        <li>Androgen-secreting tumor (ovarian, adrenal)</li>
                        <li>Cushing's syndrome</li>
                        <li>Acromegaly</li>
                    </ul>
                </td>
            </tr>
        </table>
    </p>
    <p>The ones on the left typically present with oligo-/anovulation <u>without</u> hyperandrogenism; the ones on the right typically present oligo-/anovulation <u>with</u> hyperandrogenism.</p>

</body>
</html>